MovDisordV3, PubMed, Curation, bibRecord, 001C25

Thalidomide induced acute worsening of Parkinson's disease.

Identifieur interne : 001C25 ( PubMed/Curation ); précédent : 001C24; suivant : 001C26

Thalidomide induced acute worsening of Parkinson's disease.

Auteurs : Sara C. Crystal ; John Leonidas ; Ann Jakubowski ; Alessandro Di Rocco

Source :

Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2009.

RBID : pubmed:19606491

English descriptors

KwdEn :
- Aged, Humans, Immunosuppressive Agents (adverse effects), Male, Parkinson Disease (complications), Parkinson Disease (etiology), Primary Myelofibrosis (complications), Primary Myelofibrosis (drug therapy), Thalidomide (adverse effects).
MESH :
- chemical , adverse effects : Immunosuppressive Agents, Thalidomide.
- complications : Parkinson Disease, Primary Myelofibrosis.
- drug therapy : Primary Myelofibrosis.
- etiology : Parkinson Disease.
- Aged, Humans, Male.

DOI: 10.1002/mds.22497
PubMed: 19606491

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001C25

Links to Exploration step

pubmed:19606491

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Thalidomide induced acute worsening of Parkinson's disease.</title>
<author><name sortKey="Crystal, Sara C" sort="Crystal, Sara C" uniqKey="Crystal S" first="Sara C" last="Crystal">Sara C. Crystal</name>
</author>
<author><name sortKey="Leonidas, John" sort="Leonidas, John" uniqKey="Leonidas J" first="John" last="Leonidas">John Leonidas</name>
</author>
<author><name sortKey="Jakubowski, Ann" sort="Jakubowski, Ann" uniqKey="Jakubowski A" first="Ann" last="Jakubowski">Ann Jakubowski</name>
</author>
<author><name sortKey="Di Rocco, Alessandro" sort="Di Rocco, Alessandro" uniqKey="Di Rocco A" first="Alessandro" last="Di Rocco">Alessandro Di Rocco</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="doi">10.1002/mds.22497</idno>
<idno type="RBID">pubmed:19606491</idno>
<idno type="pmid">19606491</idno>
<idno type="wicri:Area/PubMed/Corpus">001C25</idno>
<idno type="wicri:Area/PubMed/Curation">001C25</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Thalidomide induced acute worsening of Parkinson's disease.</title>
<author><name sortKey="Crystal, Sara C" sort="Crystal, Sara C" uniqKey="Crystal S" first="Sara C" last="Crystal">Sara C. Crystal</name>
</author>
<author><name sortKey="Leonidas, John" sort="Leonidas, John" uniqKey="Leonidas J" first="John" last="Leonidas">John Leonidas</name>
</author>
<author><name sortKey="Jakubowski, Ann" sort="Jakubowski, Ann" uniqKey="Jakubowski A" first="Ann" last="Jakubowski">Ann Jakubowski</name>
</author>
<author><name sortKey="Di Rocco, Alessandro" sort="Di Rocco, Alessandro" uniqKey="Di Rocco A" first="Alessandro" last="Di Rocco">Alessandro Di Rocco</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Humans</term>
<term>Immunosuppressive Agents (adverse effects)</term>
<term>Male</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson Disease (etiology)</term>
<term>Primary Myelofibrosis (complications)</term>
<term>Primary Myelofibrosis (drug therapy)</term>
<term>Thalidomide (adverse effects)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Immunosuppressive Agents</term>
<term>Thalidomide</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term>
<term>Primary Myelofibrosis</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Primary Myelofibrosis</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Humans</term>
<term>Male</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">19606491</PMID>
<DateCreated><Year>2009</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted><Year>2009</Year>
<Month>12</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>24</Volume>
<Issue>12</Issue>
<PubDate><Year>2009</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Thalidomide induced acute worsening of Parkinson's disease.</ArticleTitle>
<Pagination><MedlinePgn>1863-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.22497</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Crystal</LastName>
<ForeName>Sara C</ForeName>
<Initials>SC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Leonidas</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Jakubowski</LastName>
<ForeName>Ann</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Di Rocco</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4Z8R6ORS6L</RegistryNumber>
<NameOfSubstance UI="D013792">Thalidomide</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007166">Immunosuppressive Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D055728">Primary Myelofibrosis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013792">Thalidomide</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>7</Month>
<Day>17</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>7</Month>
<Day>17</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2009</Year>
<Month>12</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.22497</ArticleId>
<ArticleId IdType="pubmed">19606491</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C25 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001C25 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:19606491
   |texte=   Thalidomide induced acute worsening of Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:19606491" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Thalidomide induced acute worsening of Parkinson's disease.

Thalidomide induced acute worsening of Parkinson's disease.

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki